We are live on ! Find out more
ACA

Atlas Capital Advisors Portfolio holdings

AUM $875M
This Fund
S&P 500
This Quarter Est. Return
+2.79%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$304M
AUM Growth
+$27.2M
Cap. Flow
+$21.6M
Cap. Flow %
7.09%
Top 10 Hldgs %
18.78%
Holding
692
New
127
Increased
171
Reduced
175
Closed
39

Sector Composition

Rank Sector Weight
1 Technology 8.54%
2 Consumer Staples 8.34%
3 Financials 8.31%
4 Healthcare 7.72%
5 Consumer Discretionary 5.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EPOL icon
401
iShares MSCI Poland ETF
EPOL
$755M
$74.7K 0.02%
3,147
OHI icon
402
Omega Healthcare
OHI
$14.7B
$73.5K 0.02%
+2,000
New +$72.9K
DFS
403
DELISTED
Discover Financial Services
DFS
$72.9K 0.02%
940
-133
-12% -$10.3K
VGLT icon
404
Vanguard Long-Term Treasury ETF
VGLT
$10.1B
$72.7K 0.02%
890
CXW icon
405
CoreCivic
CXW
$3.17B
$72.7K 0.02%
3,500
+1,000
+40% +$21.5K
CBD
406
DELISTED
Companhia Brasileira de Distribuicao
CBD
$72.2K 0.02%
2,951
PDD icon
407
Pinduoduo
PDD
$128B
$72.2K 0.02%
3,501
SLF icon
408
Sun Life Financial
SLF
$45.3B
$72K 0.02%
1,740
EMN icon
409
Eastman Chemical
EMN
$8.55B
$71.3K 0.02%
916
-56
-6% -$4.25K
PTR
410
DELISTED
PETROCHINA COMPANY LIMITED ADS (REP 100 H SHARES)
PTR
$68.2K 0.02%
1,239
-131
-10% -$7.85K
UGP icon
411
Ultrapar
UGP
$6.84B
$67.8K 0.02%
12,948
-2,962
-19% -$16.1K
TUR icon
412
iShares MSCI Turkey ETF
TUR
$213M
$66.5K 0.02%
2,790
-3,307
-54% -$75.9K
XOM icon
413
ExxonMobil
XOM
$631B
$65.7K 0.02%
856
+523
+157% +$40.5K
TEVA icon
414
Teva Pharmaceuticals
TEVA
$40.3B
$65.5K 0.02%
7,092
-25,551
-78% -$308K
VTR icon
415
Ventas
VTR
$47.4B
$65.3K 0.02%
956
VOD icon
416
Vodafone
VOD
$37B
$65.3K 0.02%
+4,000
New +$68.8K
BT
417
DELISTED
BT Group plc (ADR)
BT
$65.1K 0.02%
5,096
-23,335
-82% -$324K
IWR icon
418
iShares Russell Mid-Cap ETF
IWR
$57B
$64.8K 0.02%
+1,160
New +$63.6K
DG icon
419
Dollar General
DG
$28.2B
$64.3K 0.02%
476
-82
-15% -$10.4K
EWU icon
420
iShares MSCI United Kingdom ETF
EWU
$4.14B
$64.1K 0.02%
1,982
+100
+5% +$3.29K
QNCX icon
421
Quince Therapeutics
QNCX
$28.4M
$63.8K 0.02%
+8
New +$47.8K
JNPR
422
DELISTED
Juniper Networks
JNPR
$63K 0.02%
2,367
SPDW icon
423
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
$41.3B
$62.7K 0.02%
2,118
+1,341
+173% +$39.5K
ACN icon
424
Accenture
ACN
$103B
$62.1K 0.02%
336
EWH icon
425
iShares MSCI Hong Kong ETF
EWH
$1.21B
$61.8K 0.02%
2,388

Similar funds

Atlas Capital Advisors's Q2 2019 Portfolio in Review

As of Q2 2019, Atlas Capital Advisors held 692 positions worth $304M, up 9.8% from $277M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Atlas Capital Advisors deployed $21.6M of net new capital in Q2 2019, opening 127 new positions and adding to 171 existing holdings. Its largest new stake was ProShares Large Cap Core Plus: 39,236 shares worth $1.38M.

By sector, the portfolio is most concentrated in Technology at 8.5% of assets, down from 8.8% a quarter earlier, followed by Consumer Staples and Financials.

On the sell side, the largest reduction was Vanguard Morningstar Small-Cap Value ETF, an estimated $1.76M trimmed.

  • Atlas Capital Advisors's largest Q2 2019 buy was ProShares Large Cap Core Plus: 39,236 shares worth $1.38M.
  • Atlas Capital Advisors added most to Vanguard FTSE Europe ETF in Q2 2019, an estimated $1.51M increase.
  • Atlas Capital Advisors's biggest Q2 2019 reduction was Vanguard Morningstar Small-Cap Value ETF, cutting an estimated $1.76M.
  • Atlas Capital Advisors fully exited Invesco Taxable Municipal Bond ETF in Q2 2019, selling an estimated $1.14M.
  • Atlas Capital Advisors's ten largest holdings make up 19% of its $304M portfolio in Q2 2019.
  • Atlas Capital Advisors opened 127 new positions and closed 39 in Q2 2019.
  • Atlas Capital Advisors's portfolio value rose 9.8% quarter-over-quarter to $304M.

Based on Atlas Capital Advisors's 13F filing for Q2 2019, filed 25 Jul 2019.